Pituitary

Article	Citations
Lateral orientation of Rathke cleft cysts may be associated with high rates of recurrence after surgery	85
Reported outcomes in transsphenoidal surgery for pituitary adenomas: a systematic review	63
Evaluation of cardiac structure, exercise capacity and electrocardiography parameters in children with partial and complete growth hormone deficiency and their changes with short term growth hormone r	40
Idiopathic central diabetes insipidus in a large cohort of patients: the hypopituitarism ENEA rare observational (HEROS) study	36
Cushing’s disease: role of bilateral adrenalectomy	36
Pituitary stalk interruption syndrome: phenotype, predictors, and pathophysiology of perinatal events	33
Diffusion-weighted imaging does not seem to be a predictor of consistency in pituitary adenomas	30
The efficacy of a visiting surgical service versus that of a hospital-based surgical service in providing endoscopic endonasal surgery to remove nonfunctioning pituitary adenomas in rural communities	29
Semaglutide treatment of hypothalamic obesity – a real-life data study	26
The impact of facility type and volume on treatment and overall survival in craniopharyngioma	26
Surgical treatment of cystic pituitary adenomas: literature-based definitions and postoperative outcomes	24
Changing the name of diabetes insipidus	23
Hypercoagulability in Cushing’s syndrome: incidence, pathogenesis and need for thromboprophylaxis protocols	22
Skeletal fragility in pituitary disease: how can we predict fracture risk?	22
Delayed postoperative hyponatremia in patients with acromegaly: incidence and predictive factors	22
Patient-reported outcomes in refractory hormone-producing pituitary adenomas: an unmet need	21
Lymphocytic panhypophysitis and anti-rabphilin-3A antibody with pulmonary sarcoidosis	21
Growth hormone insensitivity and adipose tissue: tissue morphology and transcriptome analyses in pigs and humans	21
An Infundibular Unidentified Object (IUO): a new pituitary stalk marker?	21
Recovery from hypogonadism in men with prolactinoma treated with dopamine agonists	21
When to decide on testosterone replacement despite dopamine agonist therapy in male prolactinomas?	20
Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers	19
Pituitary tumor centers of excellence (PTCOE): the next border of acromegaly treatment	19
Correction to: Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results	18
Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency	18

Historical and future trends in emergency pituitary referrals: a machine learning analysis	18
Measuring pituitary tumor volume: a comparison of the simplified and non-simplified ellipsoid equation with the 3D planimetric volume assessment	18
The microenvironment of pituitary adenomas: biological, clinical and therapeutical implications	18
Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas	18
A comparison of macular ganglion cell and retinal nerve fibre layer optical coherence tomographic parameters as predictors of visual outcomes of surgery for pituitary tumours	17
Assessment of forearm muscles with ultrasound shear wave elastography in patients with acromegaly	17
Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma	16
Demonstration of the inferior intercavernous sinus is closely linked to the extent of pneumatization of the sphenoid sinus: useful information for the pituitary surgeon	16
Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours	16
Growth hormone increase by luteinizing hormone-releasing hormone reflects gonadotroph-related characteristics in acromegaly	15
GnRH agonist-associated pituitary apoplexy: a case series and review of the literature	15
Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States	15
Proportion and predictors of Hypogonadism Recovery in Men with Macroprolactinomas treated with dopamine agonists	14
Growth hormone secreting pituitary adenomas show distinct extrasellar extension patterns compared to nonfunctional pituitary adenomas	14
Influence of growth hormone therapy on germinoma survivors	14
Medical therapy for refractory pituitary adenomas	14
Low prevalence of neuropathic-like pain symptoms in long-term controlled acromegaly	14
Substance P and Neurokinin-1 receptor are overexpressed in adamantinomatous craniopharyngioma than in the pituitary gland	13
Importance of 24 h ambulatory blood pressure monitoring in patients with acromegaly and correlation with cardiac magnetic resonance findings	13
The impact of non-clinical factors in pituitary surgery	13
Predictors of biochemical remission after transsphenoidal surgery in a large cohort of acromegaly patients	13
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience	12
Headache relief following endoscopic drainage of Rathke’s cleft cyst	12
Treatment and prognostic factors of pituicytoma: a single-center experience and comprehensive literature review	12
A study on clinical outcomes of Rathke’s cleft cyst in patients managed conservatively	12
Pituitary apoplexy score, toward standardized decision-making: a descriptive study	12
Diabetes insipidus after endoscopic transsphenoidal surgery: multicenter experience and development of the SALT score	11
An update on, and genetics of refractory adenomas of childhood	11
Pituitary metastases: a case series and scoping review	11
Cushing’s disease: adrenal steroidogenesis inhibitors	11
Comparison between extended transsphenoidal and transcranial surgery for craniopharyngioma: focus on hypothalamic function and obesity	11
TGFBR3L is associated with gonadotropin production in non-functioning gonadotroph pituitary neuroendocrine tumours	11
Machine learning models predict delayed hyponatremia post-transsphenoidal surgery using clinically available features	11
Posterior hypothalamic involvement on pre-operative MRI predicts hypothalamic obesity in craniopharyngiomas	11
Cytokines and chemokines modulate the growth of pituitary adenoma/neuroendocrine tumors: preliminary results of a monocenter prospective pilot study	11
Treatment of acromegaly-induced diabetes: an updated proposal	10
Sheehan syndrome: a current approach to a dormant disease	10
Effects of growth hormone replacement therapy in childhood-onset craniopharyngioma: an updated systematic review and meta-analysis	10
Inflammation of adenohypophysis is commonly associated with headache in surgically managed Rathke’s cleft cysts	10
Cushing’s disease: role of preoperative and primary medical therapy	10
Giant prolactinomas, a detailed analysis of 196 adult cases	10
Can we predict the risk of venous thromboembolism in patients with Cushing’s syndrome: a nationwide cohort analysis	10
Correction: Giant prolactinomas, a detailed analysis of 196 adult cases	10
Changes in pituitary adenoma patient presentation and outcomes during the COVID pandemic at a Pituitary Center of Excellence	10
The role of BRAF testing of Rathke’s cleft cysts to identify missed papillary craniopharyngioma	10
Hospital frailty risk score predicts postoperative outcomes after endoscopic endonasal resection of non-functioning pituitary adenomas	10
Exploring sex-specific hematological changes and their impact on quality of life in patients with prolactinoma	10
Pituitary: hic manebimus optime	9
Symptoms and steroid dose adjustments following the Covid-19 vaccine in patients with adrenal insufficiency	9
Problem-solving therapy can reduce psychological distress in patients with Cushing’s disease: a randomized controlled trial	9

Second-line regimen for CNS-involved pediatric Langerhans cell histiocytosis	9
Overnight 1 mg dexamethasone suppression test and 24 h urine free cortisol—accuracy and pitfalls when screening for Cushing’s syndrome	9
A patient-reported outcome measure for patients with pituitary adenoma undergoing transsphenoidal surgery	9
Refractory lactotroph adenomas	8
Prevalence of coronary calcium deposits in Sheehan’s syndrome patients on long term replacement treatment	8
Endoscopic endonasal marsupialization of rathke cleft cysts: clinical outcomes and risk factors analysis of visual impairment, pituitary dysfunction, and CSF leak	8
High prevalence of overweight/obesity and dyslipidemia in patients with intracranial germ cell tumors	8
The somatotroph pituitary gland function in high-aged multimorbid hospitalized patients with IGF-I deficiency	8
Acromegaly increases depressive symptoms and reduces quality of life of cohabitants	8
Sleep disruption in patients with active and treated endogenous Cushing’s syndrome	8
11C-methionine PET aids localization of microprolactinomas in patients with intolerance or resistance to dopamine agonist therapy	8
Evaluating the burden of endogenous Cushing’s syndrome using a web-based questionnaire and validated patient-reported outcome measures	8
Natural history of untreated microprolactinomas	8
Refractory pituitary adenomas: preface	8
Vertebral fractures in patients with non-functioning pituitary adenomas - a new frontier?	8
Neuropathic foot ulcers in the tallest patients with acromegalic gigantism: a common and significant problem. Historical overview	7
Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot single center experience	7
Basal cortisol in relation to metyrapone confirmation in predicting adrenal insufficiency after pituitary surgery	7
Double adenomas of the pituitary reveal distinct lineage markers, copy number alterations, and epigenetic profiles	7
Radiological evolution of autograft fat used for skull base reconstruction after transsphenoidal surgery for pituitary adenomas	7
Pituitary tumours without distinct lineage differentiation express stem cell marker SOX2	7
Postsurgical outcomes of nonfunctioning pituitary adenomas: a patient-level meta-analysis	7
Different patient versus provider perspectives on living with Cushing’s disease	7
Novel approach to bone comorbidity in resistant acromegaly	7
Acromegaly and pregnancy: a systematic review and meta-analysis	7
Discrimination between non-functioning pituitary adenomas and hypophysitis using machine learning methods based on magnetic resonance imaging‑derived texture features	7
HLA analysis of immune checkpoint inhibitor-induced and idiopathic isolated ACTH deficiency	7
Impact of etiology, sex, diabetes mellitus and remission status on erythrocytic profile in patients with cushing’s syndrome: a large population database study	7
Acute elevation of interleukin 6 and matrix metalloproteinase 9 during the onset of pituitary apoplexy in Cushing’s disease	7
Cardiovascular risk and glucocorticoids: a Dutch National Registry of growth hormone treatment in adults with growth hormone deficiency analysis	7
Thyrotropin-secreting pituitary adenomas induce left atrial enlargement with subclinical atrial fibrillation: an echocardiographic study	7
Venous thromboembolism chemical prophylaxis after endoscopic trans-sphenoidal pituitary surgery	7
Machine learning as a clinical decision support tool for patients with acromegaly	6
High prevalence of morphometric vertebral fractures opportunistically detected on thoracic radiograms in patients with non-functioning pituitary adenoma	6
The role of the dentist and orthodontist in recognizing oro-facial manifestations of acromegaly: a questionnaire-based study	6
Prevalence and risk of complications in untreated patients with adult growth hormone deficiency	6
Prolactin immunoassay: does the high-dose hook effect still exist?	6
Cushing’s syndrome in women: age-related differences in etiology and clinical picture	6
Pituitary apoplexy and panhypopituitarism following acute leptospirosis	6
Gigantism: microsurgical treatment by transsphenoidal approach and prognostic factors	6
Complication avoidance protocols in endoscopic pituitary adenoma surgery: a retrospective cohort study in 514 patients	6
Long-term safety of gamma knife radiosurgery (SRS) for acromegaly	6
The treatment of aggressive prolactinomas with everolimus	6
Effects of adult growth hormone deficiency and replacement therapy on the cardiometabolic risk profile	6
Implementation of functional imaging using 11C-methionine PET-CT co-registered with MRI for advanced surgical planning and decision making in prolactinoma surgery	6
Changes in multi-modality management of acromegaly in a tertiary centre over 2 decades	6
Pituitary surgery in Cushing’s disease: first line treatment and role of reoperation	5
Pituitary metastases from neuroendocrine neoplasms: case report and narrative review	5
Predicting tumor consistency and extent of resection in non-functioning pituitary tumors	5
Glucocorticoid receptor blockers	5
Correction: consensus on criteria for acromegaly diagnosis and remission	5
A fond farewell	5
Characteristics and overall survival in pediatric versus adult pituitary adenoma: a National Cancer Database analysis	5
Real-world experience with pasireotide-LAR in resistant acromegaly: a single center 1-year observation	5
Predictive value of macular ganglion cell-inner plexiform layer thickness in visual field defect of pituitary adenoma patients: a case-control study	5
Consensus on criteria for acromegaly diagnosis and remission	5
Functioning gonadotroph adenomas in premenopausal women: clinical and molecular characterization and review of the literature	5
Frailty and pituitary surgery: a systematic review	5
Surgery is a safe, effective first-line treatment modality for noninvasive prolactinomas	5
Differences between immunotherapy-induced and primary hypophysitis—a multicenter retrospective study	5
Predictive factors of postoperative diabetes insipidus in 333 patients undergoing transsphenoidal surgery for non-functioning pituitary adenoma	5
Complications and mortality of Cushing’s disease: report on data collected over a 20-year period at a referral centre	5
Headache in pituitary adenomas: frequency, characteristics and outcome after treatment	5
Exploring potential influencing factors of inadherence to specialist aftercare and long-term medication in patients with acromegaly	4
Somapacitan-induced reversible lipoatrophy in an adult woman with hypopituitarism	4
The comprehensive evaluation of oral and fecal microbiota in patients with acromegaly	4
Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results	4
Impact of patient-reported nasal symptoms on quality of life after endoscopic pituitary surgery: a prospective cohort study	4
Quality of life impairment after a diagnosis of Cushing’s syndrome	4
Predicting hypogonadotropic hypogonadism persistence in male macroprolactinoma	4
Clinical use of [18F]fluoro-ethyl-L-tyrosine PET co-registered with MRI for localizing prolactinoma remnants	4
Care trajectories of surgically treated patients with a prolactinoma: why did they opt for surgery?	4
Treatment of recurrent and persistent Cushing’s disease after first transsphenoidal surgery: lessons learned from an international meta-analysis	4
Precocious puberty, pandemic and beyond	4
Characteristics of inflammatory and infectious diseases of the pituitary gland in patients undergoing transsphenoidal surgery	4
Growth hormone (GH) deficiency and GH replacement therapy in patients previously treated for Cushing’s disease	4
Opioids and pituitary function: expert opinion	4
How to manage intolerance to dopamine agonist in patients with prolactinoma	3
Mice with gene alterations in the GH and IGF family	3
Modern imaging in Cushing’s disease	3

Does size really matter? A closer look at the absolute size of growth hormone-secreting pituitary adenomas	3
Desmopressin dose requirements in patients with permanent arginine vasopressin deficiency: a tertiary center experience	3
Surgically treated acromegaly patients have a similar quality of life whether controlled by surgery or requiring additional medical therapy (QuaLAT Study)	3
TSH-secreting pituitary adenomas and bone	3
UK practice on incidentally detected non-functioning pituitary microadenomas: analysis of two national surveys during a 12-year interval	3
Shared decision-making and detection of comorbidities in an online acromegaly consultation with and without the Acromegaly Disease Activity Tool ACRODAT® using the simulated person approach	3
Clinical and imaging findings for the evaluation of large Rathke’s cleft cysts and cystic craniopharyngiomas	3
Appearance of fluid content in Rathke’s cleft cyst is associated with clinical features and postoperative recurrence rates	3
A prospective study on the efficacy of oral estrogen in female patients with acromegaly	3
Idiopathic isolated adrenocorticotropic hormone deficiency: a systematic review of a heterogeneous and underreported disease	3
Acromegaly and COVID-19, lessons, and new opportunities	3
SARS-CoV-2 infection and vaccination in patients with pituitary diseases: the experience of a Brazilian reference center	3
Vascular anomalies in patients with growth hormone-secreting pituitary adenomas: illustrative case report and systematic review of the literature	3
IGF-1 is positively associated with BMI in patients with acromegaly	3
Correction: Development and validation of a novel treatment adherence, satisfaction and knowledge questionnaire (TASK-Q) for adult patients with hypothalamic-pituitary disorders	3
Cushing’s disease and bone	3
Is semaglutide a target therapy for acquired hypothalamic obesity?	3
The acromegaly treatment satisfaction questionnaire (Acro-TSQ): turkish adaptation, validity, and reliability study	3
How to rule out non-neoplastic hypercortisolemia (previously known as pseudo-cushing)	3
Syndrome of inappropriate antidiuresis/hyponatremia in COVID-19	3
Long-term metabolic effectiveness and safety of growth hormone replacement therapy in patients with adult growth hormone deficiency: a single-institution study in Japan	3
Hypophysitis in COVID-19: a systematic review	3
Glucose metabolism, gut-brain hormones, and acromegaly treatment: an explorative single centre descriptive analysis	3
Correction: Utility of copeptin in predicting non-pathological postoperative polyuria in patients affected by acromegaly undergoing pituitary neurosurgery	3
Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas	2
Outcomes of endoscopic endonasal surgery for pediatric craniopharyngioma with a focus on morphological preservation of the pituitary stalk and endocrine functions	2
Identifying research priorities for pituitary adenoma surgery: an international Delphi consensus statement	2
Refractory somatotroph adenomas	2
Osilodrostat improves blood pressure and glycemic control in patients with Cushing’s disease: a pooled analysis of LINC 3 and LINC 4 studies	2
Pituitary tumor centers of excellence for Cushing’s disease	2
Identification of mutant K-RAS in pituitary macroadenoma	2
Evaluation of acromegaly treatment direct costs with respect to biochemical control and follow-up length	2
Correction: Impulse control disorders in patients with dopamine agonist-treated pituitary adenomas: a cross-sectional multicenter study	2
Cardiovascular risk in patients with acromegaly vs. non-functioning pituitary adenoma following pituitary surgery: an active-comparator cohort study	2
Impact of intraoperative magnetic resonance imaging on gross total resection, extent of resection, and residual tumor volume in pituitary surgery: systematic review and meta-analysis	2
The diagnosis and prevalence of hypoprolactinemia in patients with panhypopituitarism and the effects on depression and sexual functions	2
Normative data for pituitary size and volume in the general population between 50 and 66 years	2
Medical management pathways for Cushing’s disease in pituitary tumors centers of excellence (PTCOEs)	2
Hypopituitarism and COVID-19	2
Impulse control disorders in patients with dopamine agonist-treated pituitary adenomas: a cross-sectional multicenter study	2
Glucose intolerance in acromegaly is driven by low insulin secretion; results from an intravenous glucose tolerance test	2
Reported baseline variables in transsphenoidal surgery for pituitary adenoma over a 30 year period: a systematic review	2
Surgical strategies in the treatment of MR-negative Cushing’s Disease: a systematic review and treatment algorithm	2
Prevalence of Nelson’s syndrome after bilateral adrenalectomy in patients with cushing’s disease: a systematic review and meta-analysis	2
Pituitary Tumor Centers of Excellence (PTCOE) should now include neuro-oncologic input	2
Efficacy and safety of pasireotide treatment in acromegaly: A systematic review and single arm meta-analysis	2
Paltusotine, a novel oral once-daily nonpeptide SST2 receptor agonist, suppresses GH and IGF-1 in healthy volunteers	2
Dabrafenib as a diagnostic and therapeutic strategy for the non-surgical management of papillary craniopharyngioma	2
Antiplatelet and anticoagulation therapy and the risk of pituitary apoplexy in pituitary adenoma patients	2
Psychiatric morbidity in acromegaly: a cohort study and meta-analysis of the literature	2
Hypopituitarism and bone disease: pathophysiology, diagnosis and treatment outcomes	2
Long-term clinical outcome of 103 patients with acromegaly after pituitary surgery	2
Efficacy and safety of cavernous sinus medial wall resection in pituitary adenoma surgery: a systematic review and a single-arm meta-analysis	2
Impact of medical therapy for hormone-secreting Pituitary tumors on bone	2
Generating novel pituitary datasets from open-source imaging data and deep volumetric segmentation	2
Sleep quality in patients with non-functioning pituitary adenoma: impact of replacement therapies with an emphasis on the time of hydrocortisone	2
The diverging role of O-GlcNAc transferase in corticotroph and somatotroph adenomas	2
Giant prolactinoma in children and adolescents: a single-center experience and systematic review	2
Cardiovascular health and mortality in Cushing’s disease	2